Skip to main content

Table 2 Laboratory investigations in case 2

From: COVID-19 and emergencies in patients with diabetes: two case reports

Hemoglobin g/dl [range: 14–18] 11.3 11.4 10.5 9.1 11 9.2
Hematocrit, % [range: 40–54] 34 30 33 28 34.2 27
Leukocytes, 103/ml [range: 5.0–10.0] 8.37 7.71 14.7 15.5 11.2 11.0
Neutrophils, % [range: 45–74] 70.1 63.4 91.7 93 82.2 80
Lymphocytes, % [range: 16–45] 16.0 21.9 3.9 4.7 13.2 11.1
Platelets, 103/ml [range: 150–450] 174 180 240 179 180 176
Urea, mg/dl [range: 19–44.1] 59.9 44.9 64.2 59.9 29.96  
Creatinine, mg/dl [range: 0.8–1.25] 1.48 1.22 1.77 1.28 0.69  
Na, mEq/L [range: 135–145] 133 133 167 148 140 138
K, mEq/L [range: 3.5–5.1] 4.8 4.4 4.2 4.7 4.5 3.5
AST, U/l [range: 05–34] 23 26 22    
ALT, U/l [range: 00–55] 15 17 21    
CRP, mg/ml [range: < 0.5] 0.37 0.68 5.94 1.08 1.94 0.37
  1. HbA1c—6.6 %
  2. SARS-CoV-2 rRT-PCR positive
  3. Na: Sodium, K: Potassium, AST: Aspartate Transaminase, ALT: Alanine Transaminase, CRP: c-reactive protein, HbA1c: Glycosylated hemoglobin, SARS-CoV-2 rRT-PCR: severe acute respiratory syndrome Coronavirus 2 recombinant reverse transcriptase polymerase chain reaction